APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Syndromic Diagnostic Test

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Syndromic Diagnostic Test Market Analysis and Forecast 2026-2032

Report ID 17425423022 May 2026197 pages

Choose your research edition.

Industry ResearchSyndromic Diagnostic Test Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Syndromic Diagnostic Test Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Syndromic Diagnostic Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Syndromic Diagnostic Test Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Syndromic Diagnostic Test Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Syndromic Diagnostic Test market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Syndromic Diagnostic Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Syndromic Diagnostic Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Syndromic Diagnostic Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Syndromic Diagnostic Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Syndromic Diagnostic Test include Abbott, Hologic, Applied BioCode, Danaher, Diagenode, Curetis, Bio-Rad, DiaSorin and bioMérieux, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Syndromic Diagnostic Test, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Syndromic Diagnostic Test, also provides the revenue of main regions and countries. Of the upcoming market potential for Syndromic Diagnostic Test, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Syndromic Diagnostic Test revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Syndromic Diagnostic Test market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Syndromic Diagnostic Test revenue, projected growth trends, production technology, application and end-user industry.

Syndromic Diagnostic Test Segment by Company

Abbott

Hologic

Applied BioCode

Danaher

Diagenode

Curetis

Bio-Rad

DiaSorin

bioMérieux

QIAGEN

Syndromic Diagnostic Test Segment by Type

Nucleic Acid Extraction Test

Polymerase Chain Reaction (PCR) Test

Others

Syndromic Diagnostic Test Segment by Application

Hospital

Laboratory

Research Institution

Others

Syndromic Diagnostic Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Syndromic Diagnostic Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Syndromic Diagnostic Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Syndromic Diagnostic Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Syndromic Diagnostic Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Syndromic Diagnostic Test company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Syndromic Diagnostic Test revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Syndromic Diagnostic Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Nucleic Acid Extraction Test Major Player Table 3. Polymerase Chain Reaction (PCR) Test Major Player Table 4. Others Major Player Table 5. Global Syndromic Diagnostic Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Laboratory Major Player Table 8. Research Institution Major Player Table 9. Others Major Player Table 10. Syndromic Diagnostic Test Industry Trends Table 11. Syndromic Diagnostic Test Industry Drivers Table 12. Syndromic Diagnostic Test Industry Opportunities and Challenges Table 13. Syndromic Diagnostic Test Industry Restraints Table 14. Global Syndromic Diagnostic Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Syndromic Diagnostic Test Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Syndromic Diagnostic Test Market Share by Region (2021-2026) Table 17. Global Syndromic Diagnostic Test Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Syndromic Diagnostic Test Market Share by Region (2027-2032) Table 19. Global Syndromic Diagnostic Test Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Syndromic Diagnostic Test Revenue Market Share by Players (2021-2026) Table 21. Global Syndromic Diagnostic Test Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Syndromic Diagnostic Test Key Players Headquarters & Area Served Table 23. Global Syndromic Diagnostic Test Players, Product Type & Application Table 24. Global Syndromic Diagnostic Test Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Syndromic Diagnostic Test by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Syndromic Diagnostic Test Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Syndromic Diagnostic Test Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Syndromic Diagnostic Test Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Syndromic Diagnostic Test Revenue Market Share by Type (2021-2026) Table 31. Global Syndromic Diagnostic Test Revenue Market Share by Type (2027-2032) Table 32. Global Syndromic Diagnostic Test Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Syndromic Diagnostic Test Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Syndromic Diagnostic Test Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Syndromic Diagnostic Test Revenue Market Share by Application (2021-2026) Table 36. Global Syndromic Diagnostic Test Revenue Market Share by Application (2027-2032) Table 37. Abbott Company Information Table 38. Abbott Business Overview Table 39. Abbott Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Abbott Syndromic Diagnostic Test Product Portfolio Table 41. Abbott Recent Development Table 42. Hologic Company Information Table 43. Hologic Business Overview Table 44. Hologic Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Hologic Syndromic Diagnostic Test Product Portfolio Table 46. Hologic Recent Development Table 47. Applied BioCode Company Information Table 48. Applied BioCode Business Overview Table 49. Applied BioCode Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Applied BioCode Syndromic Diagnostic Test Product Portfolio Table 51. Applied BioCode Recent Development Table 52. Danaher Company Information Table 53. Danaher Business Overview Table 54. Danaher Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Danaher Syndromic Diagnostic Test Product Portfolio Table 56. Danaher Recent Development Table 57. Diagenode Company Information Table 58. Diagenode Business Overview Table 59. Diagenode Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Diagenode Syndromic Diagnostic Test Product Portfolio Table 61. Diagenode Recent Development Table 62. Curetis Company Information Table 63. Curetis Business Overview Table 64. Curetis Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Curetis Syndromic Diagnostic Test Product Portfolio Table 66. Curetis Recent Development Table 67. Bio-Rad Company Information Table 68. Bio-Rad Business Overview Table 69. Bio-Rad Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Bio-Rad Syndromic Diagnostic Test Product Portfolio Table 71. Bio-Rad Recent Development Table 72. DiaSorin Company Information Table 73. DiaSorin Business Overview Table 74. DiaSorin Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. DiaSorin Syndromic Diagnostic Test Product Portfolio Table 76. DiaSorin Recent Development Table 77. bioMérieux Company Information Table 78. bioMérieux Business Overview Table 79. bioMérieux Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. bioMérieux Syndromic Diagnostic Test Product Portfolio Table 81. bioMérieux Recent Development Table 82. QIAGEN Company Information Table 83. QIAGEN Business Overview Table 84. QIAGEN Syndromic Diagnostic Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. QIAGEN Syndromic Diagnostic Test Product Portfolio Table 86. QIAGEN Recent Development Table 87. North America Syndromic Diagnostic Test Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Syndromic Diagnostic Test Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Syndromic Diagnostic Test Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Syndromic Diagnostic Test Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Syndromic Diagnostic Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Syndromic Diagnostic Test Revenue by Country (2021-2026) & (US$ Million) Table 93. North America Syndromic Diagnostic Test Revenue by Country (US$ Million) & (2027-2032) Table 94. Europe Syndromic Diagnostic Test Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Syndromic Diagnostic Test Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Syndromic Diagnostic Test Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Syndromic Diagnostic Test Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Syndromic Diagnostic Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Syndromic Diagnostic Test Revenue by Country (2021-2026) & (US$ Million) Table 100. Europe Syndromic Diagnostic Test Revenue by Country (US$ Million) & (2027-2032) Table 101. China Syndromic Diagnostic Test Revenue by Type (2021-2026) & (US$ Million) Table 102. China Syndromic Diagnostic Test Revenue by Type (2027-2032) & (US$ Million) Table 103. China Syndromic Diagnostic Test Revenue by Application (2021-2026) & (US$ Million) Table 104. China Syndromic Diagnostic Test Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Syndromic Diagnostic Test Revenue by Type (2021-2026) & (US$ Million) Table 106. Asia Syndromic Diagnostic Test Revenue by Type (2027-2032) & (US$ Million) Table 107. Asia Syndromic Diagnostic Test Revenue by Application (2021-2026) & (US$ Million) Table 108. Asia Syndromic Diagnostic Test Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Syndromic Diagnostic Test Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia Syndromic Diagnostic Test Revenue by Region (US$ Million) & (2021-2026) Table 111. Asia Syndromic Diagnostic Test Revenue by Region (US$ Million) & (2027-2032) Table 112. SAMEA Syndromic Diagnostic Test Revenue by Type (2021-2026) & (US$ Million) Table 113. SAMEA Syndromic Diagnostic Test Revenue by Type (2027-2032) & (US$ Million) Table 114. SAMEA Syndromic Diagnostic Test Revenue by Application (2021-2026) & (US$ Million) Table 115. SAMEA Syndromic Diagnostic Test Revenue by Application (2027-2032) & (US$ Million) Table 116. SAMEA Syndromic Diagnostic Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. SAMEA Syndromic Diagnostic Test Revenue by Country (2021-2026) & (US$ Million) Table 118. SAMEA Syndromic Diagnostic Test Revenue by Country (US$ Million) & (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Syndromic Diagnostic Test Image Figure 2. Global Syndromic Diagnostic Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Syndromic Diagnostic Test Market Size Share 2021 VS 2025 VS 2032 Figure 4. Nucleic Acid Extraction Test Image Figure 5. Polymerase Chain Reaction (PCR) Test Image Figure 6. Others Image Figure 7. Global Syndromic Diagnostic Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Syndromic Diagnostic Test Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Laboratory Image Figure 11. Research Institution Image Figure 12. Others Image Figure 13. Global Syndromic Diagnostic Test Market Size (US$ Million) & (2021-2032) Figure 14. Global Syndromic Diagnostic Test Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Syndromic Diagnostic Test Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Syndromic Diagnostic Test Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Syndromic Diagnostic Test Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Syndromic Diagnostic Test Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Syndromic Diagnostic Test Revenue Market Share by Type (2021-2032) Figure 21. Global Syndromic Diagnostic Test Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Syndromic Diagnostic Test Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Syndromic Diagnostic Test Revenue Market Share by Application (2021-2032) Figure 24. North America Syndromic Diagnostic Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Syndromic Diagnostic Test Revenue Share by Type (2021-2032) Figure 26. North America Syndromic Diagnostic Test Revenue Share by Application (2021-2032) Figure 27. North America Syndromic Diagnostic Test Revenue Share by Country (2021-2032) Figure 28. United States Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Syndromic Diagnostic Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Syndromic Diagnostic Test Revenue Share by Type (2021-2032) Figure 33. Europe Syndromic Diagnostic Test Revenue Share by Application (2021-2032) Figure 34. Europe Syndromic Diagnostic Test Revenue Share by Country (2021-2032) Figure 35. Germany Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Syndromic Diagnostic Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Syndromic Diagnostic Test Revenue Share by Type (2021-2032) Figure 45. China Syndromic Diagnostic Test Revenue Share by Application (2021-2032) Figure 46. Asia Syndromic Diagnostic Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Syndromic Diagnostic Test Revenue Share by Type (2021-2032) Figure 48. Asia Syndromic Diagnostic Test Revenue Share by Application (2021-2032) Figure 49. Asia Syndromic Diagnostic Test Revenue Share by Region (2021-2032) Figure 50. Japan Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Syndromic Diagnostic Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Syndromic Diagnostic Test Revenue Share by Type (2021-2032) Figure 58. SAMEA Syndromic Diagnostic Test Revenue Share by Application (2021-2032) Figure 59. SAMEA Syndromic Diagnostic Test Revenue Share by Country (2021-2032) Figure 60. Brazil Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Syndromic Diagnostic Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Nucleic Acid Extraction Test
  • Polymerase Chain Reaction (PCR) Test
  • Others
Applications
  • Hospital
  • Laboratory
  • Research Institution
  • Others
Companies covered
  • Abbott
  • Hologic
  • Applied BioCode
  • Danaher
  • Diagenode
  • Curetis
  • Bio-Rad
  • DiaSorin
  • bioMérieux
  • QIAGEN

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Syndromic Diagnostic Test Market by Type
  3. 1.2.1 Global Syndromic Diagnostic Test Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Nucleic Acid Extraction Test
  5. 1.2.3 Polymerase Chain Reaction (PCR) Test
  6. 1.2.4 Others
  7. 1.3 Syndromic Diagnostic Test Market by Application
  8. 1.3.1 Global Syndromic Diagnostic Test Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Laboratory
  11. 1.3.4 Research Institution
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Syndromic Diagnostic Test Market Dynamics
  1. 2.1 Syndromic Diagnostic Test Industry Trends
  2. 2.2 Syndromic Diagnostic Test Industry Drivers
  3. 2.3 Syndromic Diagnostic Test Industry Opportunities and Challenges
  4. 2.4 Syndromic Diagnostic Test Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Syndromic Diagnostic Test Market Perspective (2021-2032)
  2. 3.2 Global Syndromic Diagnostic Test Growth Trends by Region
  3. 3.2.1 Global Syndromic Diagnostic Test Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Syndromic Diagnostic Test Market Size by Region (2021-2026)
  5. 3.2.3 Global Syndromic Diagnostic Test Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Syndromic Diagnostic Test Revenue by Players
  2. 4.1.1 Global Syndromic Diagnostic Test Revenue by Players (2021-2026)
  3. 4.1.2 Global Syndromic Diagnostic Test Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Syndromic Diagnostic Test Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Syndromic Diagnostic Test Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Syndromic Diagnostic Test Key Players Headquarters & Area Served
  7. 4.4 Global Syndromic Diagnostic Test Players, Product Type & Application
  8. 4.5 Global Syndromic Diagnostic Test Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Syndromic Diagnostic Test Market CR5 and HHI
  11. 4.6.3 2025 Syndromic Diagnostic Test Tier 1, Tier 2, and Tier 3
5 Syndromic Diagnostic Test Market Size by Type
  1. 5.1 Global Syndromic Diagnostic Test Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Syndromic Diagnostic Test Revenue by Type (2021-2032)
  3. 5.3 Global Syndromic Diagnostic Test Revenue Market Share by Type (2021-2032)
6 Syndromic Diagnostic Test Market Size by Application
  1. 6.1 Global Syndromic Diagnostic Test Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Syndromic Diagnostic Test Revenue by Application (2021-2032)
  3. 6.3 Global Syndromic Diagnostic Test Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Syndromic Diagnostic Test Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Hologic
  8. 7.2.1 Hologic Company Information
  9. 7.2.2 Hologic Business Overview
  10. 7.2.3 Hologic Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Hologic Syndromic Diagnostic Test Product Portfolio
  12. 7.2.5 Hologic Recent Developments
  13. 7.3 Applied BioCode
  14. 7.3.1 Applied BioCode Company Information
  15. 7.3.2 Applied BioCode Business Overview
  16. 7.3.3 Applied BioCode Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Applied BioCode Syndromic Diagnostic Test Product Portfolio
  18. 7.3.5 Applied BioCode Recent Developments
  19. 7.4 Danaher
  20. 7.4.1 Danaher Company Information
  21. 7.4.2 Danaher Business Overview
  22. 7.4.3 Danaher Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Danaher Syndromic Diagnostic Test Product Portfolio
  24. 7.4.5 Danaher Recent Developments
  25. 7.5 Diagenode
  26. 7.5.1 Diagenode Company Information
  27. 7.5.2 Diagenode Business Overview
  28. 7.5.3 Diagenode Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Diagenode Syndromic Diagnostic Test Product Portfolio
  30. 7.5.5 Diagenode Recent Developments
  31. 7.6 Curetis
  32. 7.6.1 Curetis Company Information
  33. 7.6.2 Curetis Business Overview
  34. 7.6.3 Curetis Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Curetis Syndromic Diagnostic Test Product Portfolio
  36. 7.6.5 Curetis Recent Developments
  37. 7.7 Bio-Rad
  38. 7.7.1 Bio-Rad Company Information
  39. 7.7.2 Bio-Rad Business Overview
  40. 7.7.3 Bio-Rad Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bio-Rad Syndromic Diagnostic Test Product Portfolio
  42. 7.7.5 Bio-Rad Recent Developments
  43. 7.8 DiaSorin
  44. 7.8.1 DiaSorin Company Information
  45. 7.8.2 DiaSorin Business Overview
  46. 7.8.3 DiaSorin Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
  47. 7.8.4 DiaSorin Syndromic Diagnostic Test Product Portfolio
  48. 7.8.5 DiaSorin Recent Developments
  49. 7.9 bioMérieux
  50. 7.9.1 bioMérieux Company Information
  51. 7.9.2 bioMérieux Business Overview
  52. 7.9.3 bioMérieux Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
  53. 7.9.4 bioMérieux Syndromic Diagnostic Test Product Portfolio
  54. 7.9.5 bioMérieux Recent Developments
  55. 7.10 QIAGEN
  56. 7.10.1 QIAGEN Company Information
  57. 7.10.2 QIAGEN Business Overview
  58. 7.10.3 QIAGEN Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
  59. 7.10.4 QIAGEN Syndromic Diagnostic Test Product Portfolio
  60. 7.10.5 QIAGEN Recent Developments
8 North America
  1. 8.1 North America Syndromic Diagnostic Test Revenue (2021-2032)
  2. 8.2 North America Syndromic Diagnostic Test Revenue by Type (2021-2032)
  3. 8.2.1 North America Syndromic Diagnostic Test Revenue by Type (2021-2026)
  4. 8.2.2 North America Syndromic Diagnostic Test Revenue by Type (2027-2032)
  5. 8.3 North America Syndromic Diagnostic Test Revenue Share by Type (2021-2032)
  6. 8.4 North America Syndromic Diagnostic Test Revenue by Application (2021-2032)
  7. 8.4.1 North America Syndromic Diagnostic Test Revenue by Application (2021-2026)
  8. 8.4.2 North America Syndromic Diagnostic Test Revenue by Application (2027-2032)
  9. 8.5 North America Syndromic Diagnostic Test Revenue Share by Application (2021-2032)
  10. 8.6 North America Syndromic Diagnostic Test Revenue by Country
  11. 8.6.1 North America Syndromic Diagnostic Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Syndromic Diagnostic Test Revenue by Country (2021-2026)
  13. 8.6.3 North America Syndromic Diagnostic Test Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Syndromic Diagnostic Test Revenue (2021-2032)
  2. 9.2 Europe Syndromic Diagnostic Test Revenue by Type (2021-2032)
  3. 9.2.1 Europe Syndromic Diagnostic Test Revenue by Type (2021-2026)
  4. 9.2.2 Europe Syndromic Diagnostic Test Revenue by Type (2027-2032)
  5. 9.3 Europe Syndromic Diagnostic Test Revenue Share by Type (2021-2032)
  6. 9.4 Europe Syndromic Diagnostic Test Revenue by Application (2021-2032)
  7. 9.4.1 Europe Syndromic Diagnostic Test Revenue by Application (2021-2026)
  8. 9.4.2 Europe Syndromic Diagnostic Test Revenue by Application (2027-2032)
  9. 9.5 Europe Syndromic Diagnostic Test Revenue Share by Application (2021-2032)
  10. 9.6 Europe Syndromic Diagnostic Test Revenue by Country
  11. 9.6.1 Europe Syndromic Diagnostic Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Syndromic Diagnostic Test Revenue by Country (2021-2026)
  13. 9.6.3 Europe Syndromic Diagnostic Test Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Syndromic Diagnostic Test Revenue (2021-2032)
  2. 10.2 China Syndromic Diagnostic Test Revenue by Type (2021-2032)
  3. 10.2.1 China Syndromic Diagnostic Test Revenue by Type (2021-2026)
  4. 10.2.2 China Syndromic Diagnostic Test Revenue by Type (2027-2032)
  5. 10.3 China Syndromic Diagnostic Test Revenue Share by Type (2021-2032)
  6. 10.4 China Syndromic Diagnostic Test Revenue by Application (2021-2032)
  7. 10.4.1 China Syndromic Diagnostic Test Revenue by Application (2021-2026)
  8. 10.4.2 China Syndromic Diagnostic Test Revenue by Application (2027-2032)
  9. 10.5 China Syndromic Diagnostic Test Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Syndromic Diagnostic Test Revenue (2021-2032)
  2. 11.2 Asia Syndromic Diagnostic Test Revenue by Type (2021-2032)
  3. 11.2.1 Asia Syndromic Diagnostic Test Revenue by Type (2021-2026)
  4. 11.2.2 Asia Syndromic Diagnostic Test Revenue by Type (2027-2032)
  5. 11.3 Asia Syndromic Diagnostic Test Revenue Share by Type (2021-2032)
  6. 11.4 Asia Syndromic Diagnostic Test Revenue by Application (2021-2032)
  7. 11.4.1 Asia Syndromic Diagnostic Test Revenue by Application (2021-2026)
  8. 11.4.2 Asia Syndromic Diagnostic Test Revenue by Application (2027-2032)
  9. 11.5 Asia Syndromic Diagnostic Test Revenue Share by Application (2021-2032)
  10. 11.6 Asia Syndromic Diagnostic Test Revenue by Country
  11. 11.6.1 Asia Syndromic Diagnostic Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Syndromic Diagnostic Test Revenue by Country (2021-2026)
  13. 11.6.3 Asia Syndromic Diagnostic Test Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Syndromic Diagnostic Test Revenue (2021-2032)
  2. 12.2 SAMEA Syndromic Diagnostic Test Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Syndromic Diagnostic Test Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Syndromic Diagnostic Test Revenue by Type (2027-2032)
  5. 12.3 SAMEA Syndromic Diagnostic Test Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Syndromic Diagnostic Test Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Syndromic Diagnostic Test Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Syndromic Diagnostic Test Revenue by Application (2027-2032)
  9. 12.5 SAMEA Syndromic Diagnostic Test Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Syndromic Diagnostic Test Revenue by Country
  11. 12.6.1 SAMEA Syndromic Diagnostic Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Syndromic Diagnostic Test Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Syndromic Diagnostic Test Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst